ALPS ETF TR - MED BREAKTHGH (SBIO)

Historical Holders from Q4 2014 to Q3 2025

Symbol
SBIO
Type / Class
Equity / MED BREAKTHGH
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
2,463,410
Holdings value
$74,362,888
% of all portfolios
0%
Number of holders
37
Number of buys
13
Number of sells
-16
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of ALPS ETF TR - MED BREAKTHGH (SBIO)

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 2,463,410 $74,362,888 -$11,326,387 $38.86 37
2025 Q2 2,764,856 $74,301,622 -$3,456,421 $30.07 35
2025 Q1 2,884,515 $72,984,477 +$30,442,868 $28.52 33
2024 Q4 1,485,462 $49,097,003 +$1,990,552 $33.03 35
2024 Q3 1,434,930 $52,950,164 -$250,446 $37.33 36
2024 Q2 1,418,814 $47,816,949 -$668,734 $33.58 37
2024 Q1 1,438,262 $51,309,167 +$5,137,206 $35.75 37
2023 Q4 1,295,478 $42,712,132 -$1,463,633 $32.94 34
2023 Q3 1,344,986 $36,611,445 -$2,061,644 $27.22 35
2023 Q2 1,406,121 $44,270,591 -$128,381 $31.55 40
2023 Q1 1,408,132 $38,280,082 -$1,363,931 $27.18 37
2022 Q4 1,459,524 $44,254,889 +$14,757,407 $30.38 45
2022 Q3 963,215 $29,018,762 -$2,264,410 $30.11 40
2022 Q2 1,054,443 $29,216,470 -$6,634,393 $27.69 48
2022 Q1 1,289,137 $43,377,551 -$11,112,049 $33.64 54
2021 Q4 1,618,337 $67,537,782 +$2,754,720 $42.24 62
2021 Q3 1,463,462 $66,604,390 -$332,962 $45.51 59
2021 Q2 1,467,528 $71,788,731 -$1,972,757 $48.91 63
2021 Q1 1,505,223 $75,661,850 +$3,024,487 $50.27 67
2020 Q4 1,444,766 $74,056,022 -$1,670,344 $51.22 65
2020 Q3 1,478,637 $60,818,238 -$1,490,077 $41.13 51
2020 Q2 1,500,395 $62,744,601 +$2,563,590 $41.83 51
2020 Q1 1,465,422 $46,457,127 +$4,232,484 $31.7 44
2019 Q4 1,306,707 $55,225,451 -$2,996,716 $42.28 51
2019 Q3 1,379,578 $44,001,929 +$751,133 $31.56 45
2019 Q2 1,346,627 $48,640,787 +$2,080,334 $36.12 45
2019 Q1 1,297,189 $46,924,684 -$8,654,500 $36.18 45
2018 Q4 1,596,572 $44,998,968 -$17,931,866 $28.14 47
2018 Q3 2,142,561 $84,351,772 +$15,619,448 $39.37 54
2018 Q2 1,755,840 $65,417,636 +$16,203,717 $37.27 45
2018 Q1 1,317,259 $45,080,673 +$20,163,506 $34.22 42
2017 Q4 727,746 $23,871,263 +$3,261,647 $32.78 34
2017 Q3 617,099 $19,236,387 +$714,608 $31.17 28
2017 Q2 596,596 $16,615,003 -$3,744,751 $27.85 25
2017 Q1 739,994 $19,042,496 +$1,173,999 $25.76 27
2016 Q4 701,962 $16,118,143 -$1,261,233 $22.92 26
2016 Q3 750,229 $19,572,000 +$4,481,033 $26.1 28
2016 Q2 579,496 $13,155,068 -$998,792 $22.63 27
2016 Q1 618,604 $13,648,875 -$9,403,109 $21.91 22
2015 Q4 997,368 $31,080,512 +$12,923,911 $31.73 31
2015 Q3 575,209 $16,104,325 +$5,730,602 $27.88 29
2015 Q2 361,555 $12,842,975 +$8,982,779 $35.52 18
2015 Q1 109,334 $3,273,487 +$1,860,487 $29.91 13
2014 Q4 56,793 $1,411,000 +$1,411,000 $24.92 2